Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastases

Fig. 2

Representative flow cytometric analyses, with corresponding tables, showing the percentage changes in live, dead, late apoptotic and apoptotic Annexin-V positive CTCs, in 72 hour-chemosensitivity assays of cultured CTCs from the same individual (Case 1), demonstrating chemosensitivity to Mitomycin-C (MMC, 2 μM) (A) but not Flurouracil (5-FU, 10 μM) (B), compared to respective untreated CTC controls

Back to article page